Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early onset baldness and prostate cancer risk.
Denmark-Wahnefried W, Schildkraut JM, Thompson D, Lesko SM, McIntyre L, Schwingl P, Paulson DF, Robertson CN, Anderson EE, Walther PJ. Denmark-Wahnefried W, et al. Among authors: walther pj. Cancer Epidemiol Biomarkers Prev. 2000 Mar;9(3):325-8. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10750672
Supplement use among men with prostate cancer.
Wiygul JB, Evans BR, Peterson BL, Polascik TJ, Walther PJ, Robertson CN, Albala DM, Demark-Wahnefried W. Wiygul JB, et al. Among authors: walther pj. Urology. 2005 Jul;66(1):161-6. doi: 10.1016/j.urology.2005.01.035. Urology. 2005. PMID: 15992901
Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features.
Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, Walther PJ, Gannon M, Vollmer RT. Demark-Wahnefried W, et al. Among authors: walther pj. Urology. 2001 Jul;58(1):47-52. doi: 10.1016/s0090-4295(01)01014-7. Urology. 2001. PMID: 11445478 Clinical Trial.
Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.
Demark-Wahnefried W, Polascik TJ, George SL, Switzer BR, Madden JF, Ruffin MT 4th, Snyder DC, Owzar K, Hars V, Albala DM, Walther PJ, Robertson CN, Moul JW, Dunn BK, Brenner D, Minasian L, Stella P, Vollmer RT. Demark-Wahnefried W, et al. Among authors: walther pj. Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3577-87. doi: 10.1158/1055-9965.EPI-08-0008. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 19064574 Free PMC article. Clinical Trial.
105 results